Condition

Acromegaloid Facial Appearance Syndrome

Condition 101

What are the alternative names for Acromegaloid Facial Appearance Syndrome?

AFA syndrome
Thick lips and oral mucosa

Learn More About This Condition

Top Global Doctors

Annamaria A. Colao

Annamaria A. Colao

Serafinella P. Cannavo

Messina, 82, IT

Monica R. Gadelha

Freiburg, BW, DE

Philippe Chanson

Andrea Giustina

View All Doctors

Latest Research

Latest Advance

Study

Condition: Acromegaly
Journal: BMC endocrine disorders
Treatment Used: Somatostatin Analogues (SAs) with Pegvisomant
Number of Patients: 0
Published — August 20, 2020

This study evaluated the effectiveness of combined therapy with somatostatin analogues (drugs that block the extra release of hormones) with pegvisomant for the treatment of acromegaly (when the pituitary gland produces too much growth hormone during adulthood).

Latest Advance

Study

Condition: Metastatic Colon Adenocarcinoma
Journal: Journal of cancer research and therapeutics
Treatment Used: Oxaliplatin, Fluorouracil, and Folinic Acid Combined with Cetuximab
Number of Patients: 1
Published — July 29, 2020

This case report discusses a patient with metastatic colon adenocarcinoma (tumor in the glands of the large intestine that has spread to other organs) who was treated with oxaliplatin, fluorouracil, and folinic acid combined with cetuximab.

Latest Advance

Study

Condition: Non-Scarring Alopecia
Journal: International journal of dermatology
Treatment Used: Low-Dose Oral Inoxidil
Number of Patients: 10218
Published — June 10, 2020

The study researched the use of low-dose oral inoxidil for patients with non-scarring alopecia.

Latest Advance

Study

Condition: Acromegaly
Journal: European journal of endocrinology
Treatment Used: Fractionated Radiotherapy or Radiosurgery
Number of Patients: 352
Published — January 10, 2020

This study compared the clinical outcome of using fractionated radiotherapy or stereotactic radiosurgery to treat patients with acromegaly.

View All Latest Research

Clinical Trials

Clinical Trial

Drug

Status: Recruiting
Study Type: Drug
Participants: 10
Start Date: September 1, 2020

A Pilot Study of Empagliflozin in the Treatment of Acromegalic Cardiomyopathy

Clinical Trial

Drug

Status: Recruiting
Study Type: Drug
Participants: 140
Start Date: July 6, 2020

A Phase 3, Open-label, Single-arm, Multi-center Trial to Assess the Long-term Safety of Octreotide Subcutaneous Depot (CAM2029) in Patients With Acromegaly

Clinical Trial

Drug

Status: Recruiting
Study Type: Drug
Participants: 78
Start Date: June 25, 2020

A Phase 3, Randomized, Double-blind, Placebo-controlled, Multi-center Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot (CAM2029) in Patients With Acromegaly

Clinical Trial

Device

Status: Recruiting
Study Type: Device
Participants: 500
Start Date: April 15, 2020

Post-marketing Surveillance Study to Evaluate the Clinical Utility of ACRODAT in an International, Randomised, Non-interventional Study

View All Clinical Trials